Выбор темы
Выбор стиля шрифта
Amgen новости
12/12
💡
МНЕНИЕ: Рынок уже учитывает поглощение Horizon Therapeutics со стороны Amgen - Синара
20/08
AMGN - Сделка Инсайдера: продажа 18 августа 2022
24/05
AMGN - Сделка Инсайдера: продажа 23 мая 2022
19/05
💡
МНЕНИЕ: Акции Amgen снизились из-за новых налоговых претензий в США - SUVE
11/05
AMGN - Сделка Инсайдера: продажа 10 мая 2022
16/02
💡
МНЕНИЕ: Amgen прогнозирует долгосрочные темпы роста выручки около 5% - SUVE
08/02
💡
МНЕНИЕ: Amgen увеличила продажи только за счет препарата от COVID-19 - Синара
03/02
🔗
Seeking Alpha: My Top 10 High Yield Dividend Stocks For February 2022
02/02
🔗
Zacks Investment Research: Is a Beat Likely for Amgen (AMGN) This Earnings Season?
31/01
🔗
The Motley Fool: How to Invest in Biotech When Deep Value Has no Discernible Meaning
31/01
🔗
The Motley Fool: Are the Dow's Worst-Performing Stocks of 2021 Ready to Rebound in 2022?
30/01
🔗
Seeking Alpha: 10 Dividend Growth Stocks For January 2022
28/01
🔗
Zacks Investment Research: Can Value Investors Select Amgen (AMGN) Stock Now?
28/01
🔗
Zacks Investment Research: Why Amgen (AMGN) Might Surprise This Earnings Season
26/01
🔗
Zacks Investment Research: Amgen (AMGN) to Report Q4 Results: Wall Street Expects Earnings Growth
21/01
🔗
Zacks Investment Research: Amgen's (AMGN) KRAS Inhibitor Gets Nod in Japan for Lung Cancer
14/01
🔗
Zacks Investment Research: BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study
11/01
🔗
Zacks Investment Research: Why the Earnings Surprise Streak Could Continue for Amgen (AMGN)
11/01
🔗
Seeking Alpha: Amgen, Inc. (AMGN) CEO Robert Bradway Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)
11/01
🔗
Zacks Investment Research: Amgen (AMGN) Gains As Market Dips: What You Should Know
10/01
🔗
Seeking Alpha: Amgen: Still A Good Pick For Bargain Hunters
09/01
🔗
The Motley Fool: My 3 Top Biotech Stock Picks for 2022
09/01
🔗
Seeking Alpha: Amgen Is Still A Fit For Your Dividend Growth Portfolio
07/01
🔗
Seeking Alpha: Amgen: You Won't Regret Buying This Blue-Chip Biotech Stock
07/01
🔗
Zacks Investment Research: Amgen (AMGN) Inks Multi-Target Deal to Make Protein Therapeutics
07/01
🔗
Seeking Alpha: Amgen, Inc. (AMGN) Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Broker Conference Call - (Transcript)
07/01
🔗
PRNewsWire: AMGEN TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
06/01
🔗
Market Watch: Amgen could pay Generate Biomedicines up to $1.9 billion as part of research collaboration agreement
05/01
🔗
Market Watch: Amgen downgraded at COVID-19, pricing headwinds could push out growth inflection to next year
05/01
🔗
The Motley Fool: What Does This Label Expansion Mean for Amgen's Shareholders?
04/01
🔗
Zacks Investment Research: Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
29/12
🔗
Zacks Investment Research: Amgen (AMGN) Gains As Market Dips: What You Should Know
24/12
🔗
PRNewsWire: AMGEN TO PRESENT AT THE GOLDMAN SACHS 14TH ANNUAL HEALTHCARE CEOS UNSCRIPTED CONFERENCE
21/12
🔗
Benzinga: Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level
20/12
🔗
Benzinga: Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
20/12
🔗
Zacks Investment Research: Amgen, AstraZeneca's Asthma Drug Tezepelumab Gets FDA Nod
20/12
🔗
Benzinga: AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma
20/12
🔗
Proactive Investors: AstraZeneca and Amgen's Tezspire approved in US for severe asthma
17/12
🔗
The Motley Fool: These 2 Dividend ETFs Are a Retiree's Best Friend
08/12
🔗
Seeking Alpha: Amgen Deserves To Be An Anchor Stock For Biotech Investors
08/12
🔗
Seeking Alpha: 2 Great Blue Chips To Buy In December
06/12
🔗
The Motley Fool: 3 Must-Own Dividend Stocks in This Chaotic Market
06/12
🔗
Seeking Alpha: Buy Amgen Before Everyone Else Does
02/12
🔗
Zacks Investment Research: Amgen (AMGN) Down 7.9% Since Last Earnings Report: Can It Rebound?
02/12
🔗
Zacks Investment Research: Amgen (AMGN) Kyprolis Gets FDA Nod for Use With Darzalex Faspro
02/12
🔗
The Motley Fool: Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks of 2021?
02/12
🔗
Benzinga: Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
02/12
🔗
Seeking Alpha: Amgen's (AMGN) CEO Robert Bradway Presents at Piper Sandler 33rd Annual Healthcare Conference (Transcript)
30/11
🔗
InvestorPlace: 7 Drug Stocks to Buy Now While They're Still on Sale
28/11
🔗
The Motley Fool: 3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
26/11
🔗
The Motley Fool: Should You Buy This Giant Biotech Stock?
05/11
МНЕНИЕ: Amgen отчиталась лучше ожиданий, но понизила прогноз по выручке - SUVE
03/11
МНЕНИЕ: Amgen отчиталась за 3 квартал лучше ожиданий - Финам
07/09
Morgan Stanley снижает рекомендации по акциям Johnson & Johnson, Merck, и Amgen
Загрузить еще